Current Illinois CancerCare Clinical Trals

Metastatic


A031702

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors


A032002 (Suspended)

Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer (Suspended)


Search Again